UCLA’s Dr. Garon Discusses PD1 and PD-L1 Drugs Treating Non-Small Cell Lung Cancer

Published April 19, 2013

UCLA’s Dr. Garon Discusses PD1 and PD-L1 Drugs Treating Non-Small Cell Lung Cancer – Dr. Edward Garon, M.D., of UCLA’s Jonsson Comprehensive Cancer Center is involved in clinical trials testing new cancer drugs that treat discusses anti-PD1 a…

MCLA annual research conference a 'smorgasbord of ideas'

Filed under: drug treatment programs maryland

… will begin work as a research fellow at the Johns Hopkins University School of Medicine in Baltimore, Md., this fall. His primary research includes smoking cessation during pregnancy, and HIV/AIDS prevention, diagnosis and treatment among drug users.
Read more on Berkshire Eagle

Interim PILLAR II Results Reported During SAGES – Marketwire

Filed under: drug treatment programs maryland

Also presenting at the surgeons' event were Danny A. Sherwinter, MD, Chief Minimally Invasive and Bariatric Surgery, Associate Program Director, Maimonides Medical Center and Steven R. DeMeester, MD, Professor of Cardiothoracic Surgery, University of …
Read more on Marketwire (press release)